Related by context. All words. (Click for frequent words.) 72 relapsed MM 71 morphometric vertebral fractures 70 serum phosphorous 70 Mg Uk 70 STRIDE PD 70 CANCIDAS 70 somatostatin analog 70 pharmacokinetic characteristics 69 INVEGA ® 69 Cardiotoxicity 69 aldosterone antagonist 69 HIV HCV coinfected 69 Pemetrexed 69 Nilotinib 69 induce orthostatic hypotension 69 Mg Usa 69 INTEGRILIN R 69 invasive candidiasis 68 EDEMA3 trial 68 serum aminotransferase levels 68 moderate renal impairment 68 riociguat 68 Pharmacokinetic parameters 68 tigecycline 68 MAGE A3 ASCI 68 CYT# potent vascular disrupting 68 Daptomycin 68 aminotransferase levels 68 hematopoietic cancers 68 Fulvestrant 68 Dasatinib 68 steroid dexamethasone 68 bronchial hyperresponsiveness 68 unfractionated heparin UFH 68 Tumor Response 68 linear pharmacokinetics 68 aminotransferases 68 Nesiritide 68 hyperphenylalaninemia HPA due 68 Nebulized 68 dose proportionality 68 macrolide antibiotic 68 Haptoglobin 68 galiximab 68 haematologic 67 NATRECOR ® 67 eosinophilic pneumonia 67 AST ALT 67 Rate ORR 67 CIN2 + 67 Moxifloxacin 67 See CLINICAL PHARMACOLOGY 67 Meets Primary Endpoint 67 ritonavir boosted 67 reactogenicity 67 Tipranavir 67 Oral Fingolimod 67 Paliperidone ER 67 p# biomarker 67 serum urate levels 67 Adjuvant chemotherapy 67 Fondaparinux 67 Subgroup analysis 67 ACTEMRA TM 67 urinary N telopeptide 67 K ras mutations 67 pegylated IFN 67 Index CDAI 67 ULORIC 67 rosuvastatin #mg 67 everolimus eluting stents 67 d l leucovorin 67 biologic DMARD 67 reduce serum phosphate 67 CIMZIA ™ 67 antimuscarinic 67 Bioequivalence 67 ATACAND 67 paricalcitol 67 Peginterferon Alfa 2a 67 ertapenem 67 Acute Ischemic Stroke 67 Silodosin 67 dual endothelin receptor antagonist 67 dosing frequency 67 virologic response 67 Febrile neutropenia 67 prospectively stratified 66 Antitumor Activity 66 CP CPPS 66 Degarelix 66 Tolvaptan 66 Disease Progression 66 pharmacokinetic equivalence 66 INCB# [003] 66 LAB CGRP 66 lactate dehydrogenase LDH 66 anaphylactic reactions bronchospasm 66 Soft Tissue Sarcoma 66 maximal doses 66 Naive Patients 66 fluvastatin 66 trastuzumab Herceptin ® 66 #q# deletion syndrome 66 REMINYL ® 66 antiandrogens 66 kidney urologic 66 invasive aspergillosis 66 canakinumab 66 Randomized Double blind 66 Unfractionated Heparin 66 hematologic toxicity 66 prolonged QT interval 66 favorable pharmacokinetic profile 66 Plaque Psoriasis 66 TLUS 66 antiviral efficacy 66 ARCALYST ® 66 myocardial reperfusion 66 hematological parameters 66 PSA nadir 66 divalproex sodium 66 Cardiopulmonary bypass 66 candesartan cilexetil 66 Hypotension 66 mg BID dose 66 pharmacodynamic profiles 66 Warfarin Coumadin 66 pharmacodynamic parameters 66 Anti Bacterial Envelope 66 β blockers 66 Hormone Refractory Prostate Cancer 66 Cilostazol 66 β blocker 66 Investigational Treatment 66 APTIVUS r 66 plasma pharmacokinetics 66 ZOLINZA 66 pulmonary exacerbations 66 PREZISTA r 66 IOP lowering 66 Ranolazine 66 Diabetic Foot Ulcer 66 Teriflunomide 66 aspirin clopidogrel 66 AGHD 66 Golimumab 66 azilsartan medoxomil 66 Resistant Hypertension 66 oxycodone CR 66 CYP#A# substrate 66 HBeAg seroconversion 66 Demonstrates Efficacy 66 Aeolus Pharmaceuticals Announces 66 transaminase elevations 66 Enoxaparin 66 nicardipine 66 Ribavirin causes 65 MET amplification 65 noscapine 65 Cariprazine 65 doripenem 65 Linezolid 65 VaD 65 Non Alcoholic Steatohepatitis 65 ARCOXIA 65 Critical Limb Ischemia CLI 65 Severe Asthma 65 HER2 overexpression 65 Randomized clinical trials 65 Bosutinib 65 plus prednisone prednisolone 65 candidemia 65 Clinical Outcome 65 interferon alpha IFN alpha 65 C1 INH deficiency 65 Natalizumab 65 salmeterol fluticasone 65 NATRECOR R 65 glycated hemoglobin levels 65 antiplatelet medications 65 spirometric 65 Hyperlipidemia 65 symptomatic VTE 65 NPH insulin 65 genotypic resistance 65 renal toxicity 65 Decitabine 65 relapsing remitting MS RRMS 65 CR nPR 65 zoledronate 65 NNRTI resistance 65 pharmacokinetic interactions 65 hyperprolactinemia 65 Hematologic toxicity 65 pharmacodynamic properties 65 weekly CSBMs 65 hypercholesterolaemia 65 High Dose quadruples 65 Rilonacept 65 Acute Decompensated Heart Failure 65 infliximab monotherapy 65 Aliskiren 65 mixed hyperlipidemia 65 Prospective Randomized 65 VFEND 65 Carbidopa Levodopa 65 elevated ALT 65 Engerix B 65 mycophenolate mofetil 65 CINQUIL 65 Hepatotoxicity 65 ZYVOX 65 Demonstrate Significant 65 intravascular hemolysis 65 sitaxsentan 65 Leukemias 65 Refractory Angina 65 Cethromycin 65 Relapsing Multiple Sclerosis 65 Inhaled Nitric Oxide 65 budesonide foam 65 complement inhibitor eculizumab 65 Tasigna prolongs 65 Doxil ® 65 Prostate AdenoCarcinoma Treatment 65 XIENCE V PROMUS Stent 65 Zemplar Capsules 65 Nocturia 65 FUSILEV enhances 65 NPM1 mutation 65 CLINICAL PHARMACOLOGY 65 Safinamide 65 PREZISTA r arm 65 metabolic alkalosis 65 Liprotamase 65 recurrent glioma 65 primidone 65 clomipramine 65 adjunctive ABILIFY 65 hemostatic efficacy 65 Relapsing Remitting Multiple Sclerosis 65 brand ciclesonide HFA 65 protease inhibitor PI 65 pathophysiological effects 65 Adalimumab 65 demonstrated antitumor activity 65 By JENNIFER LEARN 65 Alagebrium 65 Noxafil 65 Cytotoxicity 65 recurrent glioblastoma multiforme 65 serum clusterin levels 65 mg eq 65 TAXUS Express Stent 65 Carvedilol 65 gadobutrol 65 dose atorvastatin 65 EXJADE 65 intensive statin therapy 65 metastatic neuroendocrine tumors 65 Exacerbation 65 serum leptin 65 dyslipidaemia 65 octreotide LAR 65 MGd 65 CIMZIA TM certolizumab pegol 65 CTEPH 65 argatroban 65 allogeneic HSCT 65 Randomized Evaluation 65 Aflibercept 65 Randomised 65 Sapacitabine 65 R# #mg BID 65 memantine Namenda 65 echocardiographic parameters 65 Hydroxyurea 65 vapreotide acetate 65 LEVAQUIN ® 65 PLX STROKE targeting 65 Bucindolol 65 paroxetine sertraline 65 Myelosuppression 65 TMC# r 65 neurologic progression 65 venlafaxine XR 65 NNT = 65 oral FTY# 65 ziconotide 65 Sanofi Pasteur Fluzone 65 antidepressant efficacy 65 Ziprasidone 65 AA Amyloidosis 65 Overactive Bladder 65 Bivalirudin 65 amoxicillin clavulanate 65 headache abdominal pain 65 Catheter Associated 65 liposomal amphotericin B 65 JAK Inhibitor 65 thalidomide Thalomid 65 titrated glipizide 65 Major Depressive Disorder MDD 65 hypereosinophilic syndrome 65 Toxicities 65 HPA axis suppression 65 FluCAM arm 65 ULTRAM ER 65 noninferiority 65 postoperative chemotherapy 65 certolizumab 65 CRESTOR #mg 65 PEGINTRON TM 65 dopaminergic therapy 65 viral kinetics 65 Unstable Angina 64 Darusentan 64 dose Iluvien 64 fosamprenavir 64 Fluorouracil 64 idraparinux 64 pyridostigmine 64 ORAL Solo 64 sorafenib Nexavar 64 CIMZIA R 64 Capecitabine 64 Prehypertension 64 Venous thromboembolism 64 leukopenia pancytopenia thrombocytopenia 64 BEXXAR Therapeutic Regimen 64 Dementia Related Psychosis 64 antidepressants fluoxetine 64 Demonstrates Positive 64 J Am Coll 64 Atypical Hemolytic Uremic Syndrome 64 Carotid Revascularization Endarterectomy vs. 64 proton MR spectroscopy 64 R lenalidomide 64 efalizumab 64 cytopenias 64 concomitant medications 64 isoproterenol 64 sorafenib tablets 64 Telithromycin 64 INSPIRE Trial Phase III 64 prospectively defined 64 highly emetogenic 64 Cervical Dysplasia 64 systemic corticosteroid 64 NS5B polymerase 64 SGPT 64 novel VDA molecule 64 Rigel R# 64 tacrolimus ointment 64 GAMMAGARD 64 SPRYCEL ® 64 Desvenlafaxine Succinate 64 metastatic malignant 64 baseline FEV 64 HMG CoA reductase inhibitors 64 adrenal suppression 64 nephrotoxicity 64 ENMD # 64 Intravenous immunoglobulin 64 Cholinesterase Inhibitors 64 Renal Insufficiency 64 thromboembolic complications 64 nitroprusside 64 extrapyramidal symptoms 64 Peginterferon 64 included exfoliative dermatitis 64 plasma kallikrein inhibitor 64 desvenlafaxine succinate 64 ancrod 64 lichen planus 64 prednisone prednisolone plus 64 Tiotropium 64 HIF PH inhibitors 64 neutropenia dehydration dyspnea 64 hsCRP levels 64 acute mania 64 samalizumab 64 colorectal adenoma 64 DULERA 64 Platinol ® 64 SSRI SNRI 64 Treating Chronic 64 symptomatic hyponatremia 64 Active Ulcerative Colitis 64 systemic immunosuppressive drugs 64 aspartate aminotransferase 64 J Antimicrob Chemother 64 refractory chronic lymphocytic 64 Known hypersensitivity 64 HER2 expression 64 Pooled Analysis 64 LHRH agonists 64 ADCS CGIC 64 baseline HbA1c 64 ASCUS 64 severe exacerbations 64 Hematologic 64 oral rivaroxaban 64 finasteride Proscar 64 conventional DMARDs 64 receiving XGEVA 64 FOLPI 64 Crit Rev 64 Navelbine 64 Prolongs Survival 64 rFVIIa 64 VICTOR E3 64 hemagglutination inhibition 64 Severe Sepsis 64 Infusion Reactions Severe 64 pharmacodynamic effects 64 flavopiridol 64 Raptiva r 64 Adefovir 64 cardiac toxicity 64 doxorubicin docetaxel 64 BENICAR HCT 64 neutrophil counts 64 baseline LDH 64 NB S# strontium malonate 64 SSc 64 bezafibrate 64 human Chorionic Gonadotropin 64 glomerular filtration 64 cisplatin gemcitabine 64 Chronic HCV 64 Malignant Glioma 64 myoblast therapy 64 imipenem 64 erlotinib Tarceva ® 64 liver histology 64 bacterial prostatitis 64 IFN beta 64 bullous 64 abacavir lamivudine 64 Perforomist ™ Inhalation Solution 64 icatibant 64 decompensated liver disease 64 conditional logistic regression 64 mL/min/#.# m 2 64 busulfan 64 PEGylated anti 64 neutropenic patients 64 evaluating tivozanib 64 SPRIX ® 64 FDG PET imaging 64 oncologic outcomes 64 Relapsing remitting MS 64 severe renal impairment 64 FOLFOX4 64 Luvox fluvoxamine 64 Double Blind Randomized 64 Complicated Skin 64 statin monotherapy 64 STRATEGY FOR AN OPEN 64 Xelox 64 PASI scores 64 thromboembolic events 64 haloperidol Haldol 64 heparin induced thrombocytopenia 64 postoperative morbidity 64 nondiabetic patients 64 CYP#D# genotype 64 Secondary Hyperparathyroidism 64 oral antidiabetes 64 symptomatic pulmonary embolism 64 Cardiorespiratory fitness 64 Sipuleucel T 64 Lubiprostone 64 oxcarbazepine 64 amisulpride 64 pomalidomide 64 nadolol 64 Estrogen Receptor 64 Castration Resistant Prostate Cancer 64 SCIg 64 Glatiramer acetate 64 sUA 64 Sustained virologic response 64 Folfox 64 Renal Cell Carcinoma 64 adjunctive placebo 64 antitumor efficacy 64 antibody titer 64 del 5q MDS 64 sargramostim 64 Vidofludimus 64 pegylated interferons 64 linaclotide treated 64 oral Hycamtin 64 eplerenone 64 Anticoagulation 64 PEGylated interferon beta 1a 64 pyrexia mucositis sepsis febrile 64 analgesic efficacy 64 primary immunodeficiency PI 64 Interferon Beta 64 BYSTOLIC 64 MEVACOR 64 recurrent VTE 64 xanthine oxidase inhibitor 64 pegylated liposomal doxorubicin 64 Myocardial Perfusion Imaging 64 undergoing elective percutaneous 64 Bronchiectasis 64 ARB telmisartan 64 BARACLUDE ® 64 Hospital Acquired Pneumonia 64 QTc prolongation 64 coronary stent merged 64 pretreatment serum 64 ALA PDT 64 EEG abnormalities 64 mertansine 64 Orthostatic hypotension 64 Methylnaltrexone 64 T#I [002] 64 Atomoxetine 64 radiochemotherapy 64 efavirenz EFV 64 Improves Outcomes 64 multivariate Cox 64 ALT elevation 64 transcranial Doppler ultrasound 64 Shows Promise Against 64 platelet inhibitor 64 analgesic medications 64 Shows Efficacy 64 virological response 64 active comparator 64 alfa 2a 64 potentially hepatotoxic 64 Vidaza ® 64 Stent thrombosis 64 Symptom severity 64 Peginterferon alfa 2b 64 interferon ribavirin 64 Peg riba 63 ANAVEX #-# [001] 63 maximally tolerated dose 63 antiandrogen 63 tolvaptan 63 CYP#A# CYP#D# 63 adenoma recurrence 63 ARIXTRA 63 Uncontrolled hypertension 63 tolerability pharmacokinetics 63 echinocandin 63 Hyperkalemia 63 lipid lowering agents 63 Temsirolimus 63 Kaplan Meier analysis 63 hyperammonemia 63 CorVue ™ 63 Danazol 63 Arch Intern Med 63 LHRH antagonists 63 acute humoral rejection 63 Am J Cardiol 63 cilostazol 63 Advanced Melanoma 63 mITT population 63 cidofovir 63 diarrhea predominant irritable 63 lumbar spine BMD 63 Epratuzumab 63 Patients Treated With 63 Subgroup analyzes 63 statistical significance p 63 Gleevec resistant 63 Zeldox 63 prochlorperazine 63 Octreolin 63 Pegylated Liposomal Doxorubicin 63 Orthostatic Hypotension 63 meropenem 63 chronic eosinophilic leukemia 63 Parnate 63 evaluating mipomersen 63 pegylated interferon alfa 63 SRBD 63 Antihypertensive 63 indinavir 63 LVNC 63 NAVISTAR R 63 nonnucleoside reverse transcriptase inhibitors 63 HBeAg negative 63 Trandolapril 63 5-FU/LV 63 Oral corticosteroids 63 tocilizumab 63 Virulizin ® 63 adrenal insufficiency 63 Nephrol Dial Transplant 63 Microwave Ablation System 63 danazol 63 oxycodone IR 63 HIV coinfected 63 thiopurine drugs 63 Treatment Shows Promise 63 serotonin norepinephrine reuptake inhibitor 63 Prostate specific antigen 63 antiangiogenic agent 63 FTC TDF 63 Adjuvant therapy 63 Clostridium Difficile Associated 63 Ceplene/IL-2 63 rilonacept 63 anemia hemoglobin 63 Phase 2b Clinical Trial 63 either acutely decompensated 63 infusional 63 hemodilution 63 APTIVUS 63 erythema nodosum 63 leukotriene receptor antagonists 63 serum calcium levels 63 Thrombocytopenia 63 tipranavir 63 Bipolar Mania 63 Lenalidomide 63 serum biomarkers 63 Anti Tumor Activity 63 posaconazole 63 antiepileptics 63 trimethoprim sulfamethoxazole 63 deep venous thromboses 63 clevidipine 63 thromboprophylaxis 63 docetaxel Taxotere ® 63 venous thromboembolic disease 63 Paliperidone 63 herpetic keratitis 63 SUSTENNA TM 63 Exacerbations 63 noninfectious uveitis 63 EDARBI 63 serum testosterone 63 Ranibizumab 63 bronchodilatory 63 ONGLYZA saxagliptin 63 ST Elevation Myocardial 63 Acute Bacterial Sinusitis ABS 63 ALT flares 63 leiomyomas 63 nitrofurantoin 63 vitamin B# folic acid 63 Gel repository corticotropin injection 63 AAG geldanamycin analog 63 DOXIL 63 epoprostenol 63 lopinavir r arm 63 intravesical therapy 63 severe hypersensitivity reactions 63 nasopharyngitis headache 63 adriamycin 63 PegIFN RBV 63 PEGylated Fab fragment 63 Romiplostim 63 Virologic 63 Primary endpoints 63 alfuzosin 63 cEVR 63 teriflunomide 63 Tolerability 63 seroprotection 63 oral anticoagulation 63 Zoraxel 63 Viral load 63 R Saizen R 63 Postoperative complications 63 Zollinger Ellison Syndrome 63 Solorel TM 63 MADRS score 63 NOXAFIL 63 Serious adverse reactions 63 IBS C 63 Drug Prevents 63 commercializes implantable 63 CIMZIA TM 63 beta 1a 63 Renal Function 63 Omacetaxine 63 vWD 63 Vascugel 63 recurrent genital herpes 63 unstable angina pectoris 63 clazosentan 63 caspofungin 63 Novel Oral 63 Ramelteon 63 cranial irradiation 63 tapentadol ER 63 Refractory Hodgkin Lymphoma 63 systemic corticosteroids 63 Allergic Rhinitis 63 Severe Primary IGFD 63 GnRH agonists 63 immunocompetent patients 63 Achieves Primary Endpoint 63 pulmonary dysfunction 63 paroxysmal AF 63 symptomatic intracranial hemorrhage 63 inhibit platelet function 63 pharmacokinetic PK profile 63 glycosylated hemoglobin HbA1c 63 homocysteine concentrations 63 Tyrosine Kinase Inhibitor 63 Helicobacter pylori eradication 63 melphalan prednisone 63 irinotecan cisplatin 63 TYGACIL 63 Dabigatran etexilate 63 folinic acid 63 TNF antagonist 63 octreotide acetate 63 definite stent thrombosis 63 diabetic kidney 63 Androxal TM 63 miconazole Lauriad ® 63 Retreatment 63 Primary Hypercholesterolemia 63 Angioedema 63 topical calcineurin inhibitors 63 anagrelide 63 myopathy rhabdomyolysis 63 LymphoStat B belimumab 63 Fluticasone 63 RE LY ® 63 neovascular 63 atherothrombotic disease 63 TNF Tumor Necrosis Factor 63 Levels Linked 63 Ozarelix 63 ACCORD Lipid 63 recurrent venous thromboembolism 63 quetiapine risperidone 63 exhaled nitric oxide 63 mild renal insufficiency 63 Statistically Significant 63 PROSTVAC VF 63 immunomodulatory agents 63 ritonavir boosted lopinavir 63 secondary efficacy endpoint 63 Etanercept 63 briakinumab 63 receptor inhibitor 63 proctitis 63 Interferon beta 1b 63 cTnI 63 tipranavir r 63 AGILECT R 63 TAXUS Liberte Long 63 fluticasone salmeterol 63 randomized multicenter trial 63 Phase 2b Trial 63 adalimumab Humira 63 trastuzumab Herceptin R 63 COPAXONE R glatiramer acetate 63 micafungin 63 drotrecogin alfa activated 63 Clinical Efficacy 63 Hsp# Inhibitor 63 Decompensated Heart Failure 63 intra abdominal abscess 63 stable angina 63 CYT# QbG# 63 Anti Tumor 63 % Confidence Interval 63 TWYNSTA 63 Tocilizumab 63 Navelbine ® 63 cardiac repolarization 63 Newly Diagnosed Multiple Myeloma 63 ST Segment Elevation 63 hyperalgesia 63 serologically active systemic lupus 63 Valcyte tablets 63 Betaferon R 63 Histologic 63 Fludarabine 63 basal bolus regimen 63 oral levofloxacin 63 Deforolimus 63 interferon gamma 1b 63 Teriparatide 63 hyperuricaemia 63 % Caprylate Chromatography 63 Posaconazole 63 Fidaxomicin 63 constipation OIC 63 seropositivity 63 myelofibrosis polycythemia vera 63 uricase 63 Uterine Cancer 63 myelodysplastic myeloproliferative diseases 63 Oral Formulation 63 choroidal neovascularization 63 Bare Metal Stent 63 noninferior 63 PCWP 63 tipranavir ritonavir 63 ACE Inhibitors 63 Therapeutic Efficacy 63 rosuvastatin Crestor 63 VIIBRYD 63 lenalidomide Revlimid R 63 elevated LDH 63 postmenopausal osteoporotic women 63 Unstable angina 63 binary restenosis 63 pain palliation 63 NMIBC 63 Telbivudine 63 bFGF 63 tapentadol IR 63 peritumoral brain edema 63 calcineurin inhibitors 63 Lamotrigine 63 Demonstrated Significant 63 alefacept 63 OMNARIS HFA 63 colesevelam HCl 63 Thrombus Aspiration 63 complete cytogenetic response 63 abdominal adiposity 63 5 Fluorouracil 63 esophageal candidiasis 63 CCyR 63 RoACTEMRA 63 Aprotinin 63 dose pravastatin 63 Thromboembolic 63 atorvastatin #mg 63 follicular lymphomas 63 NOMID 63 FFNS 63 platelet dysfunction 63 Mitoxantrone 63 pharmacologically active isomer 63 HeFH 63 intracranial hypertension 63 acne vulgaris 63 adult chronic ITP 63 Immunosuppression 63 CTAP# Capsules 63 Treatment Naive Patients 63 effector function 63 Cloretazine 63 Negative Symptoms 63 pegylated interferon alpha 63 Brief Psychiatric 63 Adjuvant Treatment 63 carotid IMT 63 fosbretabulin 63 HPV-#/# 63 Granulocyte Colony Stimulating Factor 63 ADPKD 63 serum lipid levels 63 reboxetine 63 intracranial stenosis 63 Benazepril 63 NDA Submission 63 Randomized trials 63 MP4OX 63 Crohn Disease Activity 63 quetiapine XR 63 dexamethasone Decadron 63 Pegloticase 63 Aortic Stenosis 63 MDS MPD 63 DEB# 63 Clostridium difficile Infection 63 Cervista HPV HR 63 hypophosphatemia 63 First Patient Enrolled 63 RhuDex R 63 NMDA antagonists 63 G CSFs 63 ACE inhibitor ramipril 63 ADAS Cog 63 salmeterol fluticasone propionate 63 PTNS 63 Ann Oncol 63 significant cytopenia eg 63 histological subtype 63 keloid scarring 63 Desvenlafaxine 63 severe neutropenia 63 euthymic patients 63 endothelin receptor antagonists 63 subependymal giant cell 63 oral prodrug 63 Intervention Effectiveness 63 maximal tolerated 63 virologic failure 63 beta lactam antibiotic 63 acetylcysteine 63 lispro 62 mediastinitis 62 CC genotype 62 CHAMPION PCI 62 Ambrisentan 62 Emtriva Viread 62 PREZISTA ritonavir 62 therapeutic regimens 62 pentoxifylline 62 moderate hepatic impairment 62 Community Acquired Pneumonia 62 urine albumin 62 cefazolin 62 affective psychosis 62 Cytarabine 62 â ‰ ¥ 62 adenosine injection 62 triglyceride concentrations 62 QT interval prolongation 62 mecamylamine 62 ELOXATIN 62 abnormal cytology 62 OHR/AVR# 62 CYPHER R Sirolimus eluting 62 thyrotropin levels 62 empiric treatment 62 Phase 2a Trial 62 onset diabetes mellitus 62 candidate TNFerade biologic 62 Levaquin levofloxacin 62 Microalbuminuria 62 coagulation assays 62 Radical prostatectomy 62 inhaled bronchodilators 62 HBsAg 62 TRAIL R1 62 Initiates Clinical Trial 62 Antitumor 62 eculizumab therapy 62 Subgroup Analysis 62 anti androgen 62 rheumatoid arthritis osteoarthritis ankylosing 62 ACR# responses 62 transdermal estradiol 62 metastatic GIST 62 Alphanate R 62 Multivariate logistic regression 62 standard chemotherapy regimen 62 Glatiramer Acetate 62 YONDELIS 62 Suicidality 62 Ophena TM 62 Autologous Stem Cell Transplantation 62 Cognitive impairment 62 atypical Hemolytic Uremic Syndrome 62 therapeutic equivalence 62 Gastrointestinal Stromal Tumors 62 hematologic parameters 62 Advair HFA 62 -#.# log# copies mL 62 cause cardiac channelopathies 62 davunetide intranasal AL 62 Prospective Randomized Trial 62 K#N 62 Patency 62 Coronary Artery Bypass Graft 62 Atopic Dermatitis 62 CYPHER R Sirolimus Eluting 62 calculated creatinine clearance 62 Bronchopulmonary Dysplasia 62 intravesical infusion therapy 62 serum concentrations 62 Bisphosphonate 62 Certolizumab 62 CSF biomarkers 62 relapsing multiple sclerosis 62 See CONTRAINDICATIONS 62 basiliximab 62 postexposure 62 FOLFOX6 62 IV bisphosphonates 62 Adenomas 62 oral diclofenac 62 Percutaneous Tibial Nerve Stimulation 62 Candesartan 62 logistic regression analysis 62 Hb A1C 62 tolterodine 62 guanfacine extended release 62 flurpiridaz F 62 oxypurinol 62 ARCALYST ® rilonacept 62 Clinical Trial Results 62 coronary stenosis 62 failure ADHF